Lv52
1540 积分 2025-05-07 加入
Rapid manufactured CAR-T cells enriched for CD45RA-negative T cells exhibit superior persistence compared to conventional CAR-T therapy
4天前
已完结
A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma
7天前
已完结
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study
1个月前
已完结
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
2个月前
已完结
Geriatric assessment in older adults with non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper
3个月前
已完结
Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era
3个月前
已完结
Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study
3个月前
已完结
MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications
3个月前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
